Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Enantioselective gold(I)-catalysed alkyne hydroarylations for inherently chiral calix[4]arenes

Mehri Goudarzia, Anuruddha Alagiyawannab, Andrea Serafinob, Silvia Rizzatoc, Francesco Bertocchib, Francesca Terenzianib, Stefano Santorod, Wenling Qine, Gianpiero Cera*b and Valentina Pirovano*a
aDipartimento di Scienze Farmaceutiche, Sezione di Chimica Generale e Organica “A. Marchesini”, Università degli Studi di Milano, Via G. Venezian 21, 20133, Milano, Italy. E-mail: valentina.pirovano@unimi.it
bDipartimento di Scienze Chimiche, della Vita e della Sostenibilità Ambientale, Università di Parma, Parco Area delle Scienze 17/A, I-43124 Parma, Italy. E-mail: gianpiero.cera@unipr.it
cDipartimento di Chimica, Università degli Studi di Milano, Via C. Golgi 19, 20133, Milano, Italy
dDipartimento di Chimica, Biologia e Biotecnologie, Via Elce di Sotto, 8, 06123 Perugia, Italy
eChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, 401331, P. R. China

Received 1st August 2025 , Accepted 14th September 2025

First published on 15th September 2025


Abstract

We report enantioselective gold(I)-catalysed hydroarylation of alkynes to access inherently chiral calix[4]arenes. This method delivered a family of macrocycles, embedded with phenanthrene motifs, with good yields and enantioselectivities. Investigations of the photophysical and chiroptical properties revealed interesting fluorescence features, suggesting potential applications in materials science and devices.


Hydroarylation reactions represent a powerful tool to construct organic molecules with many applications in the field of organic chemistry.1 In this context, gold catalysis has been established as a versatile method able to transform modular alkyne derivatives into useful building blocks or materials in the most atom- and step-economical manner.2 In particular, enantioselective gold-catalysed hydroarylation of alkynes has been applied for the synthesis of chiral compounds characterised by non-trivial axial,3 planar4 or helical5 stereogenic elements (Scheme 1a and b). Recently, the scientific community has witnessed an increased interest in developing asymmetric catalytic methods to synthesize inherently chiral compounds.6 This type of chirality arises from the introduction of “a curvature in an ideal planar structure that is devoid of symmetry axes in its bidimensional representation”.7 Among such organic compounds, inherently chiral calix[4]arenes (ICCs) are now in high demand.8 This is demonstrated by numerous enantioselective catalytic methods that have been developed recently for the construction of such macrocycles in an asymmetric manner.9 ICCs find many applications in chemosensory, medicinal chemistry, or materials science.10 Moreover, their unique features have been employed to build synthetic molecular receptors11 and catalysts.12 Based on precedent studies,13 we now exploit enantioselective gold catalysis for the construction of inherent chirality. The functionalisation of 1 at its meta position,8b via gold-catalysed hydroarylation of alkynes,13b results in the desymmetrisation of the macrocycle, producing the targeted inherently chiral calix[4]arene 2 (Scheme 1c).
image file: d5cc04405g-s1.tif
Scheme 1 “State-of-the-art” for enantioselective gold-catalysed hydroarylations of alkynes: (a) synthesis of axial, planar and (b) helical chiral compounds; (c) our work.

Calix[4]arenes are known to adopt several distinct conformations beyond the most common cone (i.e. partial cone, 1,3-alternate and 1,2-alternate). The latter arise from the rotation of the phenolic rings around the methylene bridges. However, the well-defined cone conformation offers an ideal platform to develop enantioselective catalytic desymmetrisations.9b–j Hence, it gives a rigid bowl-shaped geometry that helps the catalysts to discriminate the enantiotopic faces. In contrast, in non-cone conformations, the spatial arrangement is less defined, rendering asymmetric catalytic reactions more challenging. For this reason, we began our investigation with the synthesis of model calix[4]arene 1a, “frozen” in a cone conformation.14 The presence of bulky propyl groups at the lower-rim of the macrocycle is necessary to make calix[4]arenes 1a and 2a configurationally stable, thus preventing the “oxygen-through the annulus” rotation.15 We then focused on optimising the enantioselective cyclisation reaction by screening a series of chiral gold(I) catalysts (Table 1; see the SI for full screening).

Table 1 Optimisation of the reaction conditionsa

image file: d5cc04405g-u1.tif

Entry [Au] AgX 2b (%) e.rc
a Reaction conditions: 1a (0.065 mmol), [Au] (2.5 or 5 mol%), AgNTf2 (5 mol%) in anhydrous 1,2-DCE (0.65 ml, 0.1 M) at rt for 1 h.b Isolated yield.c Enantiomeric ratios (e.r.) were determined by chiral HPLC. See the SI for full experimental details.d Toluene (0.1 M) as the solvent.e CH2Cl2 (0.1 M) as the solvent.f Reaction performed at 0 °C for 18 hours.
1 [L1AuCl] AgNTf2 99 74[thin space (1/6-em)]:[thin space (1/6-em)]26
2 [L2AuCl] AgNTf2 89 57[thin space (1/6-em)]:[thin space (1/6-em)]43
3 [L3(AuCl)2] AgNTf2 89 43[thin space (1/6-em)]:[thin space (1/6-em)]57
4 [L4(AuCl)2] AgNTf2 87 72[thin space (1/6-em)]:[thin space (1/6-em)]28
5 [L5(AuCl)2] AgNTf2 91 70[thin space (1/6-em)]:[thin space (1/6-em)]31
6 [L6(AuCl)2] AgNTf2 91 86[thin space (1/6-em)]:[thin space (1/6-em)]14
7 [L6(AuCl)2] AgSbF6 87 87[thin space (1/6-em)]:[thin space (1/6-em)]13
8 [L6(AuCl)2] AgBF4 80 86[thin space (1/6-em)]:[thin space (1/6-em)]14
9 [L6(AuCl)2] AgOTf 87 86[thin space (1/6-em)]:[thin space (1/6-em)]14
10d [L6(AuCl)2] AgSbF6 65 48[thin space (1/6-em)]:[thin space (1/6-em)]52
11e [L6(AuCl)2] SbF6 99 90[thin space (1/6-em)]:[thin space (1/6-em)]10
12ef [L6(AuCl)2] SbF6 95 93[thin space (1/6-em)]:[thin space (1/6-em)]7


Initially, chiral phosphoramidite–gold complexes [L1AuCl] (bearing a 2-naphthyl group at the C3/C′3 positions) and [L2AuCl] (9-pyrenyl) were tested. While both gave excellent yields of 2a (99% and 89%, respectively), the enantioselectivities were modest or low (e.r. = 74[thin space (1/6-em)]:[thin space (1/6-em)]26 and 57[thin space (1/6-em)]:[thin space (1/6-em)]43, respectively; entries 1 and 2). We next explored bidentate chiral ligands, such as L3 and L4, belonging to the BIPHEP family. [L3(AuCl)2] afforded 2a in an 89% yield but with poor enantiocontrol, while [L4(AuCl)2] gave slightly improved enantioselectivity (e.r. = 72[thin space (1/6-em)]:[thin space (1/6-em)]28), though still unsatisfactory (entries 3 and 4). The (R)-DTBM-Segphos complex [L5(AuCl)2] performed similarly to L4 (entry 5), whereas (R)-DM-Segphos [L6(AuCl)2] delivered 2a in a 91% yield and a promising e.r. of 86[thin space (1/6-em)]:[thin space (1/6-em)]14 (entry 6). With L6 as the most effective ligand, we examined the influence of the counterion. The use of AgSbF6 resulted in a slight improvement in enantioselectivity (entry 7). Other counterions tested in the gold(I)-catalysed hydroarylation proved less effective (entries 8 and 9). In contrast, switching the solvent to toluene negatively affected the reaction, giving racemic 2a in a 65% yield. Dichloromethane, on the other hand, improved both the yield and the enantiomeric ratio (99%, e.r. = 90[thin space (1/6-em)]:[thin space (1/6-em)]10), and was selected as the optimal reaction medium (entry 11). Finally, performing the reaction at 0 °C for 18 hours led to a satisfactory e.r. of 93[thin space (1/6-em)]:[thin space (1/6-em)]7 and a 95% yield (entry 12). With the optimized reaction conditions, we next evaluated the generality of the transformation by testing a series of functionalized calix[4]arenes 1b–p (Scheme 2).


image file: d5cc04405g-s2.tif
Scheme 2 Scope of the reaction. Reaction conditions: 1b–p (0.065 mmol), [L6(AuCl)2] (2.5 mol%), AgSbF6 (5 mol%) in anhydrous CH2Cl2 (0.1 M) at 0 °C for 18 hours. Isolated yields are reported. g[thin space (1/6-em)]At room temperature.

At the outset, modifications at the lower rim of the calix[4]arene core were examined. Tetrahexyl- and tetraoctyloxy-substituted calix[4]arenes 1b and 1c afforded the corresponding hydroarylated products 2b and 2c in high yields (81% and 85%) with enantiomeric ratios of 89[thin space (1/6-em)]:[thin space (1/6-em)]11 and 90[thin space (1/6-em)]:[thin space (1/6-em)]10, respectively. An even higher yield was obtained using the ethoxylated scaffold 1d, which delivered 2d in a 94% yield, albeit with a slightly lower enantioselectivity (e.r. = 87[thin space (1/6-em)]:[thin space (1/6-em)]13). Keeping the tetrapropyl alkyl chain at the lower rim, we then introduced substituents with various electronic properties in the phenylacetylene ring. The reaction proved tolerant to a range of electron-withdrawing groups (F, Cl, CF3, CO2Me, NO2) at the meta-position with respect to the alkyne moiety, affording the corresponding products 2e–i in yields ranging from 71% to 99% and enantiomeric ratios of up to 93[thin space (1/6-em)]:[thin space (1/6-em)]7.

Similar results were obtained with halogens at the para-position: fluoro-, chloro- derivatives 2j and 2k were isolated in 87% and 79% yields, respectively, both with an e.r. of 90[thin space (1/6-em)]:[thin space (1/6-em)]10. In contrast, the methoxycarbonyl-substituted product 2l showed lower reactivity and selectivity (48%, e.r. = 71[thin space (1/6-em)]:[thin space (1/6-em)]29). Likewise, difluoro-calix[4]arene 1m was less reactive, giving 2m in a 61% yield and an e.r. of 88[thin space (1/6-em)]:[thin space (1/6-em)]12. Electron-donating groups were also tolerated at various positions of the calix[4]arene scaffold. Hence, meta-OMe and para-OBn afforded the corresponding products 2n and 2o in moderate to excellent yields (68 and 94%, respectively). However, these reactions required higher temperatures (room temperature instead of 0 °C), and enantiocontrol was slightly reduced (e.r. = 86[thin space (1/6-em)]:[thin space (1/6-em)]14 and 88[thin space (1/6-em)]:[thin space (1/6-em)]12, respectively). Finally, thiophene-containing product 2p could also be synthesized, albeit with modest yield (51%) and poor enantioselectivity. The structure and absolute configuration of the ICCs were further elucidated through X-ray single-crystal diffraction analysis of calix[4]arene 2f and 2k.

Four of the new ICCs were chosen for complete characterization of the (chiro-)optical properties, particularly 2a (the reference compound), 2f (meta chloride), 2h (meta CO2Et) and 2i (meta nitro). Absorption, fluorescence and circular dichroism (CD) spectra were collected in two solvents of different polarity, hexane and dichloromethane (DCM). The main data in CH2Cl2 are reported in Fig. 1 (spectra in hexane in Fig. S1) and summarized in Table S1 (see the SI). All the compounds are characterized by strong absorption (ε ∼ 30[thin space (1/6-em)]000–60[thin space (1/6-em)]000 L mol−1 cm−1) in the UV. Compounds 2a, 2f and 2h show weakly allowed transitions (ε ∼ 100–1000 L mol−1 cm−1) around 330–340 nm, likely of charge transfer (CT) nature. Since fluorescence emission always stems from the lowest-energy excited state, the observed Stokes shifts are very large (Fig. 1 and Table S1). For calixarene 2i, the lowest-energy absorption band is quite intense and solvatochromic, moving from 345 nm in hexane to 360 in CH2Cl2, confirming the CT nature of the transition. Unfortunately, 2i has no detectable emission in hexane, while in CH2Cl2 a red-shifted, broad emission band is recorded, associated with the same CT transition. In general, quantum yields are higher, and fluorescence lifetimes are longer in CH2Cl2 than in hexane (Table S1). All the compounds show positive CD peaks in the region of the main absorption bands in the visible range, while the sign changes for the band in the UV. 2i also has a broad CD-active band at ∼350 nm, associated with the CT transition, while for the other compounds these low-energy bands are extremely weak, as already observed in absorption. The dissymmetry factors (gabs = Δε/ε) are plotted in Fig. S2. The |gabs| are in general about 10−3, indicating weak chiroptical activity, consistent with the small dimensions of the inherently chiral chromophore. The highest |gabs| are observed for 2f, reaching values >2 × 10−3.


image file: d5cc04405g-f1.tif
Fig. 1 Absorption (blue lines, left axes, molar extinction coefficient units), emission (green lines, arbitrary units) and CD spectra (red lines, right axes, Δε = εL − εR) of compounds 2a, 2f, 2h and 2i in CH2Cl2.

Finally, we investigated the origin of the observed enantioselectivity by means of DFT calculations (see the SI for details). We located twelve transition states (TSs) for each enantiomeric product, for the gold-catalysed C–C bond formation (see relative energies and the optimized structures of selected TSs in Fig. 2). The TS associated with the lowest energy (P_tilt_out_O2_C1) leads to the formation of the experimentally observed major enantiomer P, while the lowest energy TS leading to the enantiomer M (M_tilt_in_O2_C2) is only 0.6 kcal mol−1 higher in energy. This energy difference would correspond to a 74[thin space (1/6-em)]:[thin space (1/6-em)]26 e.r. However, a few TSs are similar in energy, and would thus contribute to the product distribution. Boltzmann averaging all possible TS energies gives an 83[thin space (1/6-em)]:[thin space (1/6-em)]17 e.r., in good agreement with the experimental results. Regarding the origin of the enantioselectivity, comparing the lowest energy TSs suggests that P_tilt_out_O2_C1 is less sterically crowded than M_tilt_in_O2_C2. Moreover, the Au–Au interatomic distance is shorter in P_tilt_out_O2_C1 than in M_tilt_in_O2_C2 (3.13 vs. 3.28 Å), which could also contribute to the enantioselectivity of the reaction. In conclusion, we have developed the first enantioselective gold(I)-catalysed hydroarylation of alkynes for inherently chiral calix[4]arenes. Despite the intrinsic complexity of achieving high enantiocontrol in these sterically demanding alkynyl-functionalised macrocycles,16 the method is general, operationally simple, and affords a broad range of ICCs in good yields and moderate to good enantioselectivities. Complementary computational studies rationalised the observed selectivities, while detailed chiroptical and photophysical analyses revealed structural and electronic properties that influence the optical behaviour of the final products. This catalytic method paves the way for the gold catalysed enantioselective synthesis of other calix[n]arene macrocycles.


image file: d5cc04405g-f2.tif
Fig. 2 Relative energies of the DFT-optimized transition states (top) and lowest energy transition states leading to the two enantiomers (bottom).

Dr Elisa Brambilla is gratefully acknowledged. Mass spectrometry analyses were performed at the MS facility of the Unitech COSPECT (University of Milan). We acknowledge the CINECA award under the ISCRA initiative, for the availability of high performance computing resources and support. This work has benefited from the equipment and framework of the COMP-HUB and COMP-R Initiatives, funded by the “Departments of Excellence” program of the Italian Ministry for University and Research (MIUR, 2018-2022 and MUR, 2023-2027). This project was funded by the Italian MIUR (PRIN 20227Z3BL8).

Conflicts of interest

There are no conflicts to declare.

Data availability

The data supporting this article have been included as part of the supplementary Information (SI). See DOI: https://doi.org/10.1039/d5cc04405g.

CCDC 2476429 (2f) and 2476430 (2k) contain the supplementary crystallographic data for this paper.17a,b

Notes and references

  1. L. Ackermann, T. B. Gunnoe and L. G. Habgood. Catalytic Hydroarylation of Carbon-Carbon Multiple Bonds, Wiley-VCH, Weinheim Germany, 2018 Search PubMed.
  2. (a) T. Ghosh, J. Chatterjee and S. Bhakta, Org. Biomol. Chem., 2022, 20, 7151 RSC; (b) G. Zuccarello, I. Escofet, U. Caniparoli and A. M. Echavarren, ChemPlusChem, 2021, 86, 1283 CrossRef PubMed; (c) R. Dorel and A. M. Echavarren, Chem. Rev., 2015, 115, 9028 Search PubMed.
  3. (a) Y.-B. Wang, W. Liu, T. Li, Y. Lu, Y.-T. Yu, H.-T. Liu, M. Liu, P. Li, P.-C. Qian, H. Tang, J. Guan, L.-W. Ye and L. Li, J. Am. Chem. Soc., 2024, 146(49), 33804 CrossRef PubMed; (b) Q. Gaignard-Gaillard, X. Han, A. Alix, C. Bour, R. Guillot, V. Gandon and A. Voituriez, Adv. Synth. Catal., 2022, 364, 4415 CrossRef; (c) J. Zhang, M. Simon, C. Golz and M. Alcarazo, Angew. Chem., Int. Ed., 2020, 59, 5647 CrossRef PubMed; (d) M. Satho, Y. Shibata, Y. Kimura and K. Tanaka, Eur. J. Org. Chem., 2016, 4465 CrossRef.
  4. (a) P.-C. Zhang, Y.-L. Li, J. He, H.-H. Wu, Z. Li and J. Zhang, Nat. Commun., 2021, 12, 4609 Search PubMed; (b) A. Urbano, G. Hernández-Torres, A. M. del Hoyo, A. Martínez-Carrióna and M. C. Carreño, Chem. Commun., 2016, 52, 6419 Search PubMed.
  5. (a) L. D. M. Nicholls, M. Marx, T. Hartung, E. González-Fernández, C. Golz and M. Alcarazo, ACS Catal., 2018, 8, 6079 CrossRef; (b) E. González-Fernández, L. D. M. Nicholls, L. D. Schaaf, C. Farès, C. W. Lehmann and M. Alcarazo, J. Am. Chem. Soc., 2017, 139, 1428 CrossRef PubMed.
  6. M. Tang and X. Yang, Eur. J. Org. Chem., 2023, e202300738 CrossRef.
  7. (a) V. Böhmer, D. Kraft and M. Tabatabai, J. Inclusion Phenom. Mol. Recognit. Chem., 1994, 19, 17 CrossRef; (b) A. Dalla Cort, L. Mandolini, C. Pasquini and L. Schiaffino, New J. Chem., 2004, 28, 1198 RSC.
  8. (a) W. Qin and G. Cera, Chem. Rec., 2025, 25, e202400237 CrossRef CAS PubMed; (b) P. Lhoták, Org. Biomol. Chem., 2022, 20, 7377–7390 RSC.
  9. (a) S. Tong, J.-T. Li, D.-D. Liang, Y.-E. Zhang, Q.-Y. Feng, X. Zhang, J. Zhu and M.-X. Wang, J. Am. Chem. Soc., 2020, 142, 14432 CrossRef CAS; (b) X. Zhang, S. Tong, J. Zhu and M.-X. Wang, Chem. Sci., 2023, 14, 827 RSC; (c) Y.-Z. Zhang, M.-M. Xu, X.-G. Si, J.-L. Hou and Q. Cai, J. Am. Chem. Soc., 2022, 144, 22858 CrossRef CAS; (d) T. Li, Y. Zhang, C. Du, D. Yang, M.-P. Song and J.-L. Niu, Nat. Commun., 2024, 15, 7673 CrossRef CAS; (e) L. Zhang, C. Yang, X. Wang, T. Yang, D. Yang, Y. Dou and J.-L. Niu, Green Chem., 2024, 26, 10232 RSC; (f) P.-F. Qian, G. Zhou, J.-H. Hu, B.-J. Wang, A.-L. Jiang, T. Zhou, W.-K. Yuan, Q.-J. Yao, J.-H. Chen, K.-X. Kong and B.-F. Shi, Angew. Chem., Int. Ed., 2024, 63, e202412459 CrossRef CAS PubMed; (g) Y.-K. Jiang, Y.-L. Tian, J. Feng, H. Zhang, L. Wang, W.-A. Yang, X.-D. Xu and R.-R. Liu, Angew. Chem., Int. Ed., 2024, 63, e202407752 CrossRef CAS PubMed; (h) S. Yu, M. Yuan, W. Xie, Z. Ye, T. Qin, N. Yu and X. Yang, Angew. Chem., Int. Ed., 2024, 63, e202410628 CrossRef CAS; (i) X.-Y. Zhang, D. Zhu, R.-F. Cao, Y.-X. Huo, T.-M. Ding and Z.-M. Chen, Nat. Commun., 2024, 15, 9929 CrossRef CAS; (j) V. Dočekal, L. Lóška, A. Kurčina, I. Císařová and J. Veselý, Nat. Commun., 2025, 16, 4443 CrossRef PubMed.
  10. (a) G. E. Arnott, Chem. – Eur. J., 2018, 24, 1744 CrossRef CAS; (b) S.-Y. Li, Y.-W. Xu, J.-M. Liu and C.-Y. Su, Int. J. Mol. Sci., 2011, 12, 429 CrossRef CAS; (c) A. Szumna, Chem. Soc. Rev., 2010, 39, 4274 RSC.
  11. Q. He, G. I. Vargas-Zúñiga, S. H. Kim, S. K. Kim and J. L. Sessler, Chem. Rev., 2019, 119, 9753 CrossRef CAS.
  12. (a) G. Sachdeva, D. Vaya, C. M. Srivastava, A. Kumar, V. Rawat, M. Singh, M. Verma, P. Rawat and G. K. Rao, Coord. Chem. Rev., 2022, 472, 214791 CrossRef CAS; (b) O. Santoro and C. Redshaw, Coord. Chem. Rev., 2021, 448, 214173 CrossRef CAS.
  13. (a) G. Giovanardi, S. Cattani, D. Balestri, A. Secchi and G. Cera, J. Org. Chem., 2024, 89, 8486 CrossRef CAS PubMed; (b) G. Giovanardi, G. Scarica, V. Pirovano, A. Secchi and G. Cera, Org. Biomol. Chem., 2023, 21, 4072 RSC; (c) G. Cera, G. Giovanardi, A. Secchi and A. Arduini, Chem. – Eur. J., 2021, 27, 10261 CrossRef CAS.
  14. K. Iwamoto, K. Araki and S. Shinkai, J. Org. Chem., 1991, 56, 4955 CrossRef CAS.
  15. S. Shinkai, T. Arimura, H. Kawabata, H. Murakami and K. Iwamoto, J. Chem. Soc., Perkin Trans. 1, 1991, 2429 RSC.
  16. For examples using tailored-designed ligands, see: (a) G. Zuccarello, J. G. Mayans, I. Escofet, D. Scharnagel, M. S. Kirillova, A. H. Pérez-Jimeno, P. Calleja, J. R. Boothe and A. M. Echavarren, J. Am. Chem. Soc., 2019, 141, 11858 CrossRef CAS; (b) U. Caniparoli, I. Escofet and A. M. Echavarren, ACS Catal., 2022, 12, 3317 CrossRef CAS; (c) A. Franchino, À. Martí and A. M. Echavarren, J. Am. Chem. Soc., 2022, 144, 3497 CrossRef CAS PubMed; (d) I. Martín-Torres, G. Ogalla, J.-M. Yang, A. Rinaldi and A. M. Echavarren, Angew. Chem., Int. Ed., 2021, 60, 9339 CrossRef PubMed; (e) G. Zuccarello, L. J. Nannini, A. Arroyo-Bondía, N. Fincias, I. Arranz, A. H. Pérez-Jimeno, M. Peeters, I. Martín-Torres, A. Sadurní, V. García-Vázquez, Y. Wang, M. S. Kirillova, M. Montesinos-Magraner, U. Caniparoli, G. D. Núñez., F. Maseras, M. Besora, I. Escofet and A. M. Echavarren, JACS Au, 2023, 3, 1742 Search PubMed.
  17. (a) M. Goudarzi, A. Alagiyawanna, A. Serafino, S. Rizzato, F. Bertocchi, F. Terenziani, S. Santoro, W. Qin, G. Cera and V. Pirovano, CCDC 2476429: Experimental Crystal Structure Determination, 2025 DOI:10.5517/ccdc.csd.cc2p3xtk; (b) M. Goudarzi, A. Alagiyawanna, A. Serafino, S. Rizzato, F. Bertocchi, F. Terenziani, S. Santoro, W. Qin, G. Cera and V. Pirovano, CCDC 2476430: Experimental Crystal Structure Determination, 2025 DOI:10.5517/ccdc.csd.cc2p3xvl.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.